Clinical improvement by tiotropium plus olodaterol

Respir Med. 2017 Apr:125:104. doi: 10.1016/j.rmed.2016.03.010. Epub 2016 Mar 18.

Authors

Tomohiro Tamura¹, Katsunori Kagohashi¹, Hiroaki Satoh²

Affiliations

¹ Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba-Mito Kyodo General Hospital, Japan.
² Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba-Mito Kyodo General Hospital, Japan. Electronic address: hirosato@md.tsukuba.ac.jp.

PMID: 27017081
DOI: 10.1016/j.rmed.2016.03.010

No abstract available

Keywords: COPD; Olodaterol; Tiotropium.

Publication types

Letter
Comment

MeSH terms

Benzoxazines
Bronchodilator Agents*
Forced Expiratory Volume
Humans
Pulmonary Disease, Chronic Obstructive
Scopolamine Derivatives
Tiotropium Bromide*
Treatment Outcome

Substances

Benzoxazines
Bronchodilator Agents
Scopolamine Derivatives
olodaterol
Tiotropium Bromide